Somatic mosaicism in the human genome.

Area of Science:

• Genetics
• Genomic Medicine
• Molecular Biology

Background:

• Somatic mosaicism involves distinct cell populations from postzygotic mutations, affecting only parts of the body and not inherited.
• These mutations range in size and are implicated in diseases, especially cancer.
• Phenotypic outcomes depend on mutation timing, affected tissues, and pathophysiological effects.

Purpose of the Study:

• To review the strengths and weaknesses of various techniques for identifying somatic mutations.
• To highlight recent findings on the role of somatic mosaicism in disease etiology.
• To discuss the implications of somatic mosaicism in cancer and other complex diseases.

Main Methods:

• Review of array-based and cytogenetic approaches.
• Integration of second-generation sequencing technologies.
• Analysis of mutation size and impact.

Main Results:

• Second-generation sequencing enhances the identification of somatic mutations.
• Somatic mosaicism is increasingly recognized as a factor in various diseases.
• Understanding mutation timing and affected tissues is crucial for predicting outcomes.

Conclusions:

• Somatic mosaicism plays a significant role in the pathogenesis of cancer and other diseases.
• Advanced sequencing technologies are vital for characterizing somatic mutations.
• Further research is needed to fully elucidate the complex mechanisms and implications of somatic mosaicism.